Cognitive function in postmenopausal breast cancer patients one year after completing adjuvant endocrine therapy with letrozole and/or tamoxifen in the BIG 1-98 trial

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trial

(2010) Kelly-Anne Phillips et al.   BREAST

Effects of Tamoxifen and Exemestane on Cognitive Functioning of Postmenopausal Patients With Breast Cancer: Results From the Neuropsychological Side Study of the Tamoxifen and Exemestane Adjuvant Multinational Trial

(2010) Christina M. Schilder et al.   JOURNAL OF CLINICAL ONCOLOGY

The FDA-NIMH-MATRICS Guidelines for Clinical Trial Design of Cognitive-Enhancing Drugs: What Do We Know 5 Years Later?

(2010) R. W. Buchanan et al.   SCHIZOPHRENIA BULLETIN

Validity of the CogState Brief Battery: Relationship to Standardized Tests and Sensitivity to Cognitive Impairment in Mild Traumatic Brain Injury, Schizophrenia, and AIDS Dementia Complex

(2009) P. Maruff et al.   ARCHIVES OF CLINICAL NEUROPSYCHOLOGY

Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of anastrozole on cognitive performance in postmenopausal women: a randomised, double-blind chemoprevention trial (IBIS II)

(2008) Valerie A Jenkins et al.   LANCET ONCOLOGY

Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study

(2008) Barbara Collins et al.   PSYCHO-ONCOLOGY